Docplanner

Active#1 in Poland

Doctor booking marketplace and SaaS

HealthTech›doctor booking marketplace and SaaS

Founded2012

HQWarsaw

RaisedUSD ≥151M (EUR >130M)

Last roundEquity · Aug 2021

Country of originPolandListed in the Poland ranking

Where would you invest?HQ Warsaw; operations in Poland and 13 other countriesJurisdiction as cited by the ranking

Uback rankings

How the AI ranks →

Ranking	Tier	Rank	Edition	Next update
Poland · all sectors	Top 15	#1	Edition 0 – beta · September 2026	15 Dec 2026
Appointment booking · worldwide	Top 9	#3	Edition 0 (beta) · Sep 2026	18 Jan 2027

Rank historySep 2026 · #1 PolandSep 2026 · #3 Appointment bookingFirst edition: no movements yet.

Estimated valuation

AI · Poland ranking

≈ USD 1.4bnUSD 930M–2.1bn · Unicorn Medium confidence

Hundreds of k$

Millions $

Tens of M$

Hundreds of M$

Unicorn

Decacorn

Anchor: Last known equity round: Series E · USD 89.8M · May 2019
Published valuation: USD 1bn · Aug 2021 · older than 24 months, shown for reference
AI adjustment: × 3: later undisclosed round (Aug 2021) at reported USD 1bn valuation

In the Appointment booking ranking (worldwide): ≈ USD 1.6bn · USD 1.1–2.4bn · Unicorn · Medium confidence.

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Funding history

USD ≥151M (EUR >130M) raised in total

Date	Round	Amount	Type	Investors	Source
Aug 2021	Equity	Undisclosed	Equity	One Peak, Goldman Sachs	unquote.com · wirtualnemedia.pl

Rounds as cited by Uback’s rankings and their sources. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Docplanner as a PDF, on one of three angles only:

ValuationWhat is Docplanner worth?

Versus competitorsIs #1 the right rank?

Who should acquire itStrategic buyers, and why

Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication and never change the rank.

Invest

Docplanner is not open to Backers. A company opens only when a shareholder plans to sell or the company plans to raise.

Back the market instead: your intention joins a pool, passed to the local partner once it reaches critical mass.

Declare an interest in Polish startups Declare an interest in Polish healthtech Name Docplanner as a preferred company (measures demand, promises nothing)

Poland poolBelow threshold

BackersBelow threshold

Paid intention · valid for life · movable until its pool is passed on. Investing in non-listed companies carries a risk of losing all the capital invested.

Do you run Docplanner?

Claim this profile to correct data, add your logo and description, or tell Uback about an upcoming round. Claiming never changes the rank.

Claim this profile Report an upcoming round →

Are you a shareholder?

Considering selling some of your shares? Tell Uback privately. Nothing is published without your consent, and never a price or a volume.

Tell Uback privately

What the AI reads

Press & investor announcements2 sources

Read by the AI at the next edition.

Comparable companies in Poland

Full Poland ranking →

Jutro Medical#8HealthTech › AI-first primary-care clinicsHundreds of M$Infermedica#9HealthTech › AI symptom triageHundreds of M$Brainly#2EdTech › AI homework helpHundreds of M$Viktor#3AI › AI coworker agents for Slack and TeamsHundreds of M$

Investors in Docplanner: One Peak · Goldman Sachs

Sources. unquote.com · wirtualnemedia.pl

Last updated: Sep 2026Report an error

Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.